Effective patient-specific treatment of breast cancer requires the discovery of a variety of therapeutic targets in addition to typical cellular targets such as estrogen receptors (ERs), progesterone receptors, and human epidermal growth factor receptor 2. The gene discussed is ESR1; the disease is breast cancer.